<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35736521</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Detection of unsuspected cathinone and piperazine-type drugs in urine samples positive for methamphetamine and amphetamine collected in emergency departments.</ArticleTitle><Pagination><StartPage>174</StartPage><EndPage>180</EndPage><MedlinePgn>174-180</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES">To detect the presence of unsuspected and/or undeclared cathinone and piperazine-type designer drugs in methamphetamine (METH) and amphetamine users treated in emergency departments, and to compare clinical and toxicologic profiles.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Retrospective observational study of emergency department patients treated for confirmed acute intoxication by recreational drugs (METH and amphetamines) between March 2019 and December 2020. We ordered high-performance liquid chromatography with tandem mass spectrometry to detect cathinones (methylone, fluoromethcathinone, mexedrone, fluoromethamphetamine, mephedrone, methylenedioxypyrovalerone) and synthetic piperazines (meta-chlorophenylpiperazine and trifluoromethylphenylpiperazine). Demographic, clinical, and toxicologic variables were analyzed with SPSS software (version 23).</AbstractText><AbstractText Label="RESULTS">Thirty-nine patients were included: 24 (61.5%) had used METH and 15 (38.5%) an amphetamine. Synthetic cathinones were detected in samples from 11 patients (28.2%), 10 (90.9%) in the METH group and 1 (9.1%) in the amphetamine group (P = .028). The METH users had taken mephedrone (8 patients) or methylone (2 patients); the amphetamine user had taken mephedrone. None of the patients had declared use of a cathinone; nor was use suspected. The mean (SD) number of substances involved was higher among users of cathinones (3.5 [1.13] vs 2.5 [1.40] in those who took no cathinones; P = .036). Among the cathinone users, 90.9% were men, 90.9% had used METH, and 45.5% had practiced chemsex. HIV positivity was significantly associated with cathinone use (in 45.5% vs 10.7% of those not using cathinones; P = .028). All 5 of the patients who had taken cathinones and also practiced chemsex were HIV positive. Significantly more patients who had taken cathinones presented with anxiety (72.7% vs 21.43%; P = .007). No differences in clinical management were found.</AbstractText><AbstractText Label="CONCLUSION">Detection of METH in intoxicated patients should raise suspicion of probable use of a synthetic cathinone. Patients in whom new psychoactive substances are detected should be kept under observation, and clinical protocols should include referring them to addiction treatment centers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gomila Mu&#xf1;iz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de An&#xe1;lisis Cl&#xed;nicos, Hospital Universitario Son Ll&#xe0;tzer, Palma de Mallorca, Espa&#xf1;a. Grupo de Investigaci&#xf3;n en Toxicolog&#xed;a Cl&#xed;nica, Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lendoiro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Toxicolog&#xed;a, Instituto de Ciencias Forenses "Luis Concheiro", Universidade de Santiago de Compostela, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de-Castro-R&#xed;os</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Toxicolog&#xed;a, Instituto de Ciencias Forenses "Luis Concheiro", Universidade de Santiago de Compostela, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elorza Guerrero</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Toxicolog&#xed;a Cl&#xed;nica, Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de An&#xe1;lisis Cl&#xed;nicos, Unidad de Toxicolog&#xed;a Cl&#xed;nica, Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puiguriguer Ferrando</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Toxicolog&#xed;a Cl&#xed;nica, Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de Urgencias, Hospital Universitario Son Espases, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahuquillo Frias</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de An&#xe1;lisis Cl&#xed;nicos, Hospital Can Misses, Ibiza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanch&#xed;s Cort&#xe9;s</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departamento de Qu&#xed;mica, Universidad de las Islas Baleares, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcel&#xf3; Mart&#xed;n</LastName><ForeName>Bernardino</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Toxicolog&#xed;a Cl&#xed;nica, Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de An&#xe1;lisis Cl&#xed;nicos, Unidad de Toxicolog&#xed;a Cl&#xed;nica, Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Detecci&#xf3;n no sospechada de catinonas y piperacinas en pacientes consumidores de metanfetamina y anfetamina atendidos en servicios de urgencias hospitalarios.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000470">Alkaloids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>1RTM4PAL0V</RegistryNumber><NameOfSubstance UI="D000077489">Piperazine</NameOfSubstance></Chemical><Chemical><RegistryNumber>44RAL3456C</RegistryNumber><NameOfSubstance UI="D008694">Methamphetamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>540EI4406J</RegistryNumber><NameOfSubstance UI="C023665">cathinone</NameOfSubstance></Chemical><Chemical><RegistryNumber>CK833KGX7E</RegistryNumber><NameOfSubstance UI="D000661">Amphetamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000470" MajorTopicYN="N">Alkaloids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000661" MajorTopicYN="Y">Amphetamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008694" MajorTopicYN="Y">Methamphetamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077489" MajorTopicYN="N">Piperazine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Determinar la incidencia de catinonas y piperazinas, no sospechadas y/o declaradas en consumidores de metanfetamina (MANF) y anfetamina (ANF) atendidos en servicios de urgencias hospitalarios (SUH) y comparar los perfiles cl&#xed;nicos y toxicol&#xf3;gicos.</AbstractText><AbstractText Label="METODO">Estudio retrospectivo de pacientes con intoxicaci&#xf3;n aguda por drogas recreativas con MANF y ANF confirmadas anal&#xed;ticamente atendidos en 3 SUH entre marzo de 2019 y diciembre de 2020. Se detectaron por HPLC-MS/MS las catinonas [metilona, fluorometcatinona, mecedrona, fluorometanfetamina, mefedrona, metilendioxipirovalerona (MDPV)] y las piperazinas sint&#xe9;ticas [meta-clorofenilpiperazina (mCPP), trifluorometilfenilpiperazina (TFMPP)].</AbstractText><AbstractText Label="RESULTADOS">Se incluyeron 39 pacientes: 24 (61,5%) en el grupo MANF y 15 (38,5%) en el ANF. En 11 (28,2%), se detectaron catinonas sint&#xe9;ticas (grupo CAT), 10 en el grupo MANF (8 mefedrona, 2 metilona) y 1 en el grupo ANF (1 mefedrona) (90,9% vs 9,1%; p = 0,028). Ninguno de los pacientes declar&#xf3; consumo de catinonas. El n&#xfa;mero de drogas implicadas en la intoxicaci&#xf3;n fue superior en el grupo CAT (3,5 [1,13] vs 2,5 [1,40]; p = 0,036). El perfil cl&#xed;nico del grupo CAT fue: var&#xf3;n (90,9%), consumidor de MANF (90,9%) y usuario de chemsex (45,5%). El diagn&#xf3;stico de VIH se asoci&#xf3; significativamente al grupo CAT (45,5% vs 10,7%; p = 0,028). Los pacientes del grupo CAT presentaron mayor ansiedad (72,7% vs 21,4%; p = 0,007). No se hallaron diferencias en su manejo cl&#xed;nico.</AbstractText><AbstractText Label="CONCLUSIONES">La detecci&#xf3;n de MANF deber&#xed;a considerarse un dato de sospecha de consumo de catinonas sint&#xe9;ticas, y en esos casos deber&#xed;a contemplarse la detecci&#xf3;n de nuevas sustancias psicoactivas de abuso.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amphetamine.</Keyword><Keyword MajorTopicYN="N">Anfetamina.</Keyword><Keyword MajorTopicYN="N">Catinonas sint&#xe9;ticas.</Keyword><Keyword MajorTopicYN="N">Confirmaci&#xf3;n anal&#xed;tica.</Keyword><Keyword MajorTopicYN="N">Emergency department.</Keyword><Keyword MajorTopicYN="N">Intoxicaciones.</Keyword><Keyword MajorTopicYN="N">Laboratory testing.</Keyword><Keyword MajorTopicYN="N">Metanfetamina.</Keyword><Keyword MajorTopicYN="N">Methamphetamine.</Keyword><Keyword MajorTopicYN="N">Poisoning.</Keyword><Keyword MajorTopicYN="N">Servicio de urgencias.</Keyword><Keyword MajorTopicYN="N">Synthetic cathinones.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35736521</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31909909</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Amphetamine and methamphetamine poisonings attended in hospital emergency departments: clinical features and the usefulness of laboratory confirmation.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>32</EndPage><MedlinePgn>26-32</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES">To determine whether clinical and toxicologic findings differed between cases of amphetamine (AMP) and methamphetamine (mAMP) poisoning attended in 2 Balearic Island hospital emergency departments.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Retrospective observational study of AMP and mAMP cases with laboratory confirmation between 2013 and 2018. We compared clinical and toxicologic variables as well as clinical management between groups.</AbstractText><AbstractText Label="RESULTS">1) A total of 120 cases were found: 86 (71.7%) with AMP poisoning and 34 (28.3%) with mAMP poisoning. 2) Drug poisoning was confirmed by gas chromatography associated with mass spectrometry (GC-MS) in 787 urine samples found to be positive during screening. One hundred fifty-four (19.6%) were confirmed by GC-MS. Thirtyfour of them did not meet the inclusion criteria. 3) Significant differences between AMP and mAMP cases were found for age (32.3 vs 28.4 y, respectively); sex (72.1% vs 94.1% men); and Spanish nationality (64.0% vs 29.4%). Reasons for admission and clinical features also differed: the reasons were aberrant behavior (15.1% in the AMP group vs 0% in the mAMP group) and palpitations (1.2% vs 20.6%); agitation was observed in 27.9% and 8.8%, respectively. Clinical management was similar in the 2 groups. Multiple drug poisoning was detected in 76.6% patients and was more common in patients in the AMP group (82.6% vs 61.8%). The additional drugs in these cases were mainly cocaine (63.0%), cannabis (48.9%), 3,4-methylenedioxy-N-methamphetamine (MDMA) (38.0%), and alcohol (35.9%). Cannabis was detected in a significantly higher proportion in the AMP group (45.3%) than in the mAMP group (17.6%). False positives were found in 78.7% of the samples. The culprit drug was most often MDMA (71.2%).</AbstractText><AbstractText Label="CONCLUSION">AMP poisonings were associated with age over 30 years, Spanish nationality, aberrant behavior, agitation, multiple drug findings, and the use of cannabis. Poisonings caused by mAMP abuse were associated with age under 30 years, non-Spanish nationality, palpitations, and single-drug use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roset Ferrer</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Psiquiatr&#xed;a, Hospital Universitari Son Espases, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomila Mu&#xf1;iz</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de An&#xe1;lisis Cl&#xed;nicos, Hospital Universitari Son Ll&#xe0;tzer, Palma de Mallorca, Espa&#xf1;a. Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elorza Guerrero</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de An&#xe1;lisis Cl&#xed;nicos, Unidad de Toxicolog&#xed;a Cl&#xed;nica, Hospital Universitari Son Espases, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puiguriguer Ferrando</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de Urgencias, Unidad de Toxicolog&#xed;a Cl&#xed;nica, Hospital Universitari Son Espases, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leci&#xf1;ena Estean</LastName><ForeName>Mar&#xed;a &#xc1;ngeles</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Can Misses, Ibiza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuero Le&#xf3;n</LastName><ForeName>Gaspar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital Can Misses, Ibiza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahuquillo Fr&#xed;as</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de An&#xe1;lisis Cl&#xed;nicos, Hospital Can Misses, Ibiza, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripoll Vera</LastName><ForeName>Tom&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de Cardiolog&#xed;a, Hospital Universitari Son Ll&#xe0;tzer, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Socias Crespi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de Medicina Intensiva, Hospital Universitario Son Ll&#xe0;tzer, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanch&#xed;s Cort&#xe9;s</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Departamento de Qu&#xed;mica, Universidad de las Islas Baleares, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcel&#xf3; Mart&#xed;n</LastName><ForeName>Bernardino</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Espa&#xf1;a. Servicio de An&#xe1;lisis Cl&#xed;nicos, Unidad de Toxicolog&#xed;a Cl&#xed;nica, Hospital Universitari Son Espases, Palma de Mallorca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><VernacularTitle>Intoxicaciones por anfetamina y metanfetamina atendidas en los servicios de urgencias: caracter&#xed;sticas cl&#xed;nicas y utilidad de la confirmaci&#xf3;n anal&#xed;tica.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>44RAL3456C</RegistryNumber><NameOfSubstance UI="D008694">Methamphetamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>CK833KGX7E</RegistryNumber><NameOfSubstance UI="D000661">Amphetamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Emergencias. 2020 Ago;32(4):303.</RefSource><PMID Version="1">32692019</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Emergencias. 2020 Ago;32(4):303-304.</RefSource><PMID Version="1">32692020</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000661" MajorTopicYN="N">Amphetamine</DescriptorName><QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019969" MajorTopicYN="Y">Amphetamine-Related Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008694" MajorTopicYN="N">Methamphetamine</DescriptorName><QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015813" MajorTopicYN="Y">Substance Abuse Detection</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">Investigar si existen diferencias cl&#xed;nicas y toxicol&#xf3;gicas en pacientes intoxicados por anfetamina (ANF) y metanfetamina (MANF) atendidos en servicios de urgencias.</AbstractText><AbstractText Label="METODO">Estudio observacional retrospectivo de intoxicaciones por ANF y MANF con confirmaci&#xf3;n anal&#xed;tica en Baleares (2013-2018). Se compararon variables cl&#xed;nicas, toxicol&#xf3;gicas y de manejo cl&#xed;nico entre grupos.</AbstractText><AbstractText Label="RESULTADOS">1) Se incluyeron 120 pacientes, 86 (71,7%) grupo ANF y 34 (28,3%) grupo MANF. 2) La confirmaci&#xf3;n de derivados anfetam&#xed;nicos se realiz&#xf3; por cromatograf&#xed;a de gases-espectrometr&#xed;a de masas en 787 muestras de orina previamente positivas mediante un m&#xe9;todo de cribado cualitativo. Se confirmaron 154 (19,6%) muestras. De ellas, 34 fueron excluidas. 3) Se encontraron diferencias significativas entre ANF y MANF en: edad (32,3 vs 28,4 a&#xf1;os); sexo (72,1 vs 94,1% hombres); nacionalidad espa&#xf1;ola (64,0 vs 29,4%); en motivos de admisi&#xf3;n: alteraci&#xf3;n de conducta (15,1 vs 0%) y palpitaciones (1,2 vs 20,6%); y en caracter&#xed;sticas cl&#xed;nicas: agitaci&#xf3;n (27,9 vs 8,8%). No hubo diferencias de manejo cl&#xed;nico. El 76,6% de casos fueron polintoxicaciones, m&#xe1;s comunes en ANF (82,6 vs 61,8%). En estos casos se detect&#xf3; principalmente coca&#xed;na (63,0%), cannabis (48,9%), MDMA (38,0%) y alcohol (35,9%). La mayor asociaci&#xf3;n del cannabis con el grupo de ANF fue estad&#xed;sticamente significativa (45,3 vs 17,6%). La causa de los falsos positivos se identific&#xf3; en el 78,7% de muestras, siendo el MDMA (71,2%) la principal.</AbstractText><AbstractText Label="CONCLUSIONES">Se observaron diferencias entre ANF y MANF en cuanto a variables demogr&#xe1;ficas y motivo de asistencia; no obstante en esta serie hubo un alto porcentaje de polintoxicaciones.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anfetamina</Keyword><Keyword MajorTopicYN="N">Amphetamine</Keyword><Keyword MajorTopicYN="N">Confirmaci&#xf3;n anal&#xed;tica</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Intoxicaciones</Keyword><Keyword MajorTopicYN="N">Laboratory confirmation</Keyword><Keyword MajorTopicYN="N">Metanfetamina</Keyword><Keyword MajorTopicYN="N">Methamphetamine</Keyword><Keyword MajorTopicYN="N">Poisoning</Keyword><Keyword MajorTopicYN="N">Servicio de urgencias</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31909909</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>